State Street’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.47B | Buy |
301,589,865
+1,144,701
| +0.4% | +$30.5M | 0.29% | 59 |
|
|
2025
Q4 | $7.48B | Buy |
300,445,164
+1,357,756
| +0.5% | +$34.2M | 0.25% | 73 |
|
|
2025
Q3 | $7.62B | Buy |
299,087,408
+2,786,098
| +0.9% | +$68.8M | 0.26% | 65 |
|
|
2025
Q2 | $7.18B | Sell |
296,301,310
-669,218
| -0.2% | -$15.6M | 0.27% | 64 |
|
|
2025
Q1 | $7.53B | Buy |
296,970,528
+6,486,178
| +2% | +$170M | 0.31% | 57 |
|
|
2024
Q4 | $7.71B | Buy |
290,484,350
+23,750
| +0% | +$644K | 0.3% | 54 |
|
|
2024
Q3 | $8.41B | Buy |
290,460,600
+3,405,539
| +1% | +$99.3M | 0.34% | 49 |
|
|
2024
Q2 | $8.03B | Sell |
287,055,061
-3,641,923
| -1% | -$100M | 0.35% | 48 |
|
|
2024
Q1 | $8.07B | Buy |
290,696,984
+3,214,978
| +1% | +$89.2M | 0.36% | 52 |
|
|
2023
Q4 | $8.28B | Buy |
287,482,006
+4,786,068
| +2% | +$145M | 0.4% | 43 |
|
|
2023
Q3 | $9.38B | Sell |
282,695,938
-4,505,754
| -2% | -$159M | 0.52% | 30 |
|
|
2023
Q2 | $10.5B | Buy |
287,201,692
+5,374,611
| +2% | +$209M | 0.55% | 25 |
|
|
2023
Q1 | $11.5B | Sell |
281,827,081
-2,324,927
| -0.8% | -$100M | 0.65% | 23 |
|
|
2022
Q4 | $14.6B | Sell |
284,152,008
-3,460,733
| -1% | -$166M | 0.86% | 15 |
|
|
2022
Q3 | $12.6B | Buy |
287,612,741
+395,713
| +0.1% | +$19.2M | 0.8% | 15 |
|
|
2022
Q2 | $15.1B | Buy |
287,217,028
+362,823
| +0.1% | +$18.5M | 0.9% | 13 |
|
|
2022
Q1 | $14.9B | Buy |
286,854,205
+2,037,373
| +0.7% | +$106M | 0.73% | 18 |
|
|
2021
Q4 | $16.8B | Buy |
284,816,832
+5,013,651
| +2% | +$248M | 0.8% | 15 |
|
|
2021
Q3 | $12B | Buy |
279,803,181
+1,234,870
| +0.4% | +$54.7M | 0.64% | 23 |
|
|
2021
Q2 | $10.9B | Buy |
278,568,311
+3,681,456
| +1% | +$143M | 0.58% | 26 |
|
|
2021
Q1 | $9.96B | Sell |
274,886,855
-4,694,256
| -2% | -$167M | 0.57% | 26 |
|
|
2020
Q4 | $10.3B | Sell |
279,581,111
-25,121,147
| -8% | -$921M | 0.63% | 21 |
|
|
2020
Q3 | $10.6B | Sell |
304,702,258
-10,340,795
| -3% | -$363M | 0.72% | 18 |
|
|
2020
Q2 | $9.77B | Buy |
315,043,053
+6,620,100
| +2% | +$225M | 0.71% | 19 |
|
|
2020
Q1 | $9.55B | Buy |
308,422,953
+875,135
| +0.3% | +$29.8M | 0.84% | 16 |
|
|
2019
Q4 | $11.4B | Buy |
307,547,818
+1,603,835
| +0.5% | +$57.1M | 0.78% | 21 |
|
|
2019
Q3 | $10.4B | Sell |
305,943,983
-3,288,294
| -1% | -$120M | 0.78% | 19 |
|
|
2019
Q2 | $12.7B | Sell |
309,232,277
-4,296,789
| -1% | -$171M | 0.95% | 14 |
|
|
2019
Q1 | $12.6B | Buy |
313,529,066
+3,409,424
| +1% | +$137M | 0.99% | 13 |
|
|
2018
Q4 | $12.8B | Sell |
310,119,642
-440,712
| -0.1% | -$18.3M | 1.17% | 8 |
|
|
2018
Q3 | $13B | Buy |
310,560,354
+7,118,147
| +2% | +$274M | 1% | 12 |
|
|
2018
Q2 | $10.4B | Sell |
303,442,207
-6,040,578
| -2% | -$206M | 0.87% | 15 |
|
|
2018
Q1 | $10.4B | Sell |
309,482,785
-17,233,604
| -5% | -$592M | 0.88% | 15 |
|
|
2017
Q4 | $11.2B | Buy |
326,716,389
+841,804
| +0.3% | +$28.7M | 0.9% | 16 |
|
|
2017
Q3 | $11B | Sell |
325,874,585
-7,741,756
| -2% | -$249M | 0.95% | 13 |
|
|
2017
Q2 | $10.6B | Sell |
333,616,341
-3,391,261
| -1% | -$107M | 0.94% | 16 |
|
|
2017
Q1 | $10.9B | Sell |
337,007,602
-1,109,484
| -0.3% | -$35M | 0.98% | 12 |
|
|
2016
Q4 | $10.4B | Buy |
338,117,086
+11,423,740
| +3% | +$349M | 0.98% | 15 |
|
|
2016
Q3 | $10.5B | Buy |
326,693,346
+10,163,533
| +3% | +$340M | 1.06% | 10 |
|
|
2016
Q2 | $10.6B | Sell |
316,529,813
-3,761,733
| -1% | -$120M | 1.14% | 10 |
|
|
2016
Q1 | $9.01B | Sell |
320,291,546
-8,778,982
| -3% | -$251M | 0.97% | 15 |
|
|
2015
Q4 | $10.1B | Buy |
329,070,528
+136,860
| +0% | +$4.31M | 1.1% | 11 |
|
|
2015
Q3 | $9.8B | Sell |
328,933,668
-3,370,558
| -1% | -$108M | 1.14% | 9 |
|
|
2015
Q2 | $10.6B | Sell |
332,304,226
-12,412,502
| -4% | -$405M | 1.13% | 9 |
|
|
2015
Q1 | $11.4B | Buy |
344,716,728
+50,577,119
| +17% | +$1.61B | 1.17% | 7 |
|
|
2014
Q4 | $8.69B | Buy |
294,139,609
+5,304,717
| +2% | +$152M | 0.87% | 15 |
|
|
2014
Q3 | $8.1B | Buy |
288,834,892
+6,498,325
| +2% | +$182M | 0.87% | 16 |
|
|
2014
Q2 | $7.95B | Buy |
282,336,567
+2,225,494
| +0.8% | +$63.4M | 0.86% | 16 |
|
|
2014
Q1 | $8.54B | Sell |
280,111,073
-20,000,836
| -7% | -$596M | 0.97% | 15 |
|
|
2013
Q4 | $8.72B | Buy |
300,111,909
+44,347
| +0% | +$1.29M | 0.97% | 14 |
|
|
2013
Q3 | $8.17B | Buy |
300,067,562
+3,538,708
| +1% | +$96.3M | 1.01% | 14 |
|
|
2013
Q2 | $7.88B | Buy |
+296,528,854
| New | +$8.19B | 1.03% | 15 |
|
Other funds holding PFE
VCM
VPM
State Street's PFE Position: Q1 2026 in Review
State Street increased its Pfizer (PFE) stake by 0.38% in Q1 2026, buying an estimated $30.5M and bringing the position to 301,589,865 shares worth $8.47B. The position accounts for 0.29% of the portfolio, ranked #59.
State Street first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.8B in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- State Street held 301,589,865 shares of Pfizer worth $8.47B as of Q1 2026.
- State Street bought 1,144,701 Pfizer shares in Q1 2026, an estimated $30.5M.
- Pfizer made up 0.29% of State Street's portfolio in Q1 2026, its #59 holding.
- State Street first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- State Street's Pfizer position peaked at $16.8B in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.